Header Logo

HARRYS ANTONIO TORRES

TitleAssociate Professor
InstitutionMD Anderson
DepartmentInfectious Diseases, Infection Control, and Employee Health
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Torres HA, Mustafayev K, Nastoupil LJ, Shelburne SA. Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma. Lancet. 2024 Apr 06; 403(10434):1372-1373. PMID: 38582568.
      Citations:    
    2. Chiu CY, Mustafayev K, Bhatti MM, Jiang Y, Granwehr BP, Torres HA. False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clin Infect Dis. 2024 03 20; 78(3):674-680. PMID: 37930789.
      Citations:    Fields:    Translation:HumansCells
    3. Chiu CY, Jiang Y, Torres HA. Reply to "High Specificity and Low Prevalence - Important Context for HIV Testing in US Cancer Patients". Clin Infect Dis. 2023 Dec 19. PMID: 38114100.
      Citations:    Fields:    
    4. Nardo M, Yilmaz B, Nelson BE, Torres HA, Wang LS, Granwehr BP, Song J, Dalla Pria HRF, Trinh VA, Glitza Oliva IC, Patel SP, Tannir NM, Kaseb AO, Altan M, Lee SS, Miller E, Zhang H, Stephen BA, Naing A. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience. Oncologist. 2023 08 03; 28(8):714-721. PMID: 36952233; PMCID: PMC10400154.
      Citations: 1     Fields:    Translation:Humans
    5. Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E, Granwehr BP, Kaseb A, Naing A, Patel S, Shah AY, Skoulidis F, Tawbi HA, Wang L, Miller E, Zhang HC, Zurita-Saavedra A, Torres HA. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol. 2023 09 01; 118(9):1609-1617. PMID: 37307533.
      Citations:    Fields:    Translation:HumansCells
    6. Chiu CY, Ahmed S, Thomas SK, Wang LS, Mustafayev K, Fayad LE, Wierda WG, Khawaja F, Torres HA. Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors. Clin Lymphoma Myeloma Leuk. 2023 08; 23(8):610-615. PMID: 37150651.
      Citations:    Fields:    Translation:HumansCells
    7. Chiu CY, Mustafayev K, Lee HC, Manasanch EE, Yepez Guevara E, Torres HA. Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series. Leuk Lymphoma. 2023 04; 64(4):900-903. PMID: 36883878.
      Citations:    Fields:    Translation:HumansCells
    8. Jiang Y, Gorak E, Khawaja F, Granwehr B, John T, Chaftari P, Malek AE, Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Subbiah V, Siddiqui B, Bayle A, Somer R, Fern?ndez Cruz A, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Garc?a AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Chaftari AM. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12. PMID: 36715684; PMCID: PMC9981148.
      Citations:    Fields:    Translation:HumansCells
    9. Klingen JT, Mustafayev K, Yibirin M, Hwang JP, Torres HA. False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385. PMID: 36683093.
      Citations:    Fields:    Translation:HumansCells
    10. Chiu CY, Patel K, Thomas SK, Khawaja F, Dailey Garnes NJM, Lee HC, Ohanian M, Jiang Y, Wang LS, Hwang JP, Torres HA. Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int. 2023 04; 17(2):509-511. PMID: 36477692.
      Citations:    Fields:    Translation:HumansCells
    11. Torres HA, Angelidakis G, Jiang Y, Economides M, Mustafayev K, Yibirin M, Orlowski R, Champlin R, Verstovsek S, Raad I. Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies. Medicine (Baltimore). 2022 Sep 16; 101(37):e30608. PMID: 36123927; PMCID: PMC9478288.
      Citations:    
    12. Chiu CY, Zhang HC, Westin J, Hosing C, Torres HA. Hepatitis E Virus Infection in Cancer Patients. Transplant Cell Ther. 2022 11; 28(11):788.e1-788.e5. PMID: 36031077.
      Citations:    
    13. Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Garc?a-Garc?a ?, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Malek AE, Chaftari AM. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26. PMID: 36097568; PMCID: PMC9465833.
      Citations:    
    14. Yibirin M, Hosry J, Yepez Guevara E, Granwehr BP, Jiang Y, Mustafayev K, Angelidakis G, Torres HA. High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus. Eur J Gastroenterol Hepatol. 2022 10 01; 34(10):1098-1101. PMID: 36062500.
      Citations:    
    15. Angelidakis G, Pritchard H, Yibirin M, Jiang Y, Mustafayev K, Torres HA. Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational study. Diagn Microbiol Infect Dis. 2022 Jul; 103(3):115719. PMID: 35605562.
      Citations:    Fields:    Translation:HumansCells
    16. Mustafayev K, Torres H. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clin Microbiol Infect. 2022 Oct; 28(10):1321-1327. PMID: 35283317.
      Citations: 2     Fields:    
    17. Pundhir P, Roach LR, Bartek JR, Trask RP, Yibirin M, Guevara EY, Granwehr BP, Swalwell CR, Torres HA. Nursing practice is associated with high risk for hepatitis C virus infection. Clin Microbiol Infect. 2021 09; 27(9):1362-1364. PMID: 33984487.
      Citations: 1     Fields:    Translation:HumansCells
    18. Pritchard H, Hwang JP, Angelidakis G, Yibirin M, Wang L, Miller E, Torres HA. Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. J Viral Hepat. 2021 05; 28(5):844-848. PMID: 33523503; PMCID: PMC8928572.
      Citations:    Fields:    Translation:HumansCells
    19. Angelidakis G, Krishnan S, Cabrera NL, Jiang Y, Pushparaji B, Kaseb A, Torres HA. Virologic Impact of Radiotherapy in Hepatitis C Virus-Infected Patients With Hepatocellular Carcinoma. Hepatology. 2020 08; 72(2):775-777. PMID: 31944343.
      Citations: 1     Fields:    Translation:HumansCells
    20. Angelidakis G, Mahale P, Jonasch E, Jiang Y, Torres HA. Chronic hepatitis C virus infection and genitourinary cancers: A case-control study. Semin Oncol. 2020 Apr - Jun; 47(2-3):165-167. PMID: 32507667.
      Citations:    Fields:    Translation:Humans
    21. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller E, Sturgis EM, Foreman JT, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk ET, Hwang JP. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105. PMID: 32314052; PMCID: PMC9706509.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    22. Yibirin M, Pritchard H, Torres HA. False-positive Trypanosoma cruzi serology in a cancer patient receiving intravenous immunoglobulin. Diagn Microbiol Infect Dis. 2020 Aug; 97(4):115057. PMID: 32492621.
      Citations:    Fields:    Translation:HumansAnimals
    23. Hosry J, Miranda RN, Samaniego F, Angelidakis G, Torres HA. Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients. Hematol Oncol. 2020 Aug; 38(3):301-308. PMID: 32196714.
      Citations: 2     Fields:    Translation:HumansCells
    24. Malek AE, Nieto Y, Szvalb AD, Siddiqui S, Shafi MA, Hwang JP, Raad II, Torres HA. Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib. Clin Lymphoma Myeloma Leuk. 2020 03; 20(3):e124-e127. PMID: 31932250; PMCID: PMC8262650.
      Citations: 1     Fields:    Translation:HumansCells
    25. Pritchard H, Jandhyala D, Hosry J, Angelidakis G, Torres HA. Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct-acting antivirals-A prospective study. JGH Open. 2020 Jun; 4(3):541-544. PMID: 32514467; PMCID: PMC7273696.
      Citations:    
    26. Frigeni M, Visco C, Fontaine H, Goldaniga M, Visentini M, Pulsoni A, Torres HA, Peveling-Oberhag J, Rossotti R, Zaja F, Rigacci L, Merli M, Alric C, Piazza F, Gentile M, Ferrari A, Nassi L, Rattotti S, Frustaci A, Milella M, Cencini E, Defrancesco I, Ferretti VV, Bruno R, Arcaini L, Besson C, Dorival C, Pirisi M, Hermine O. Interferon-free compared to interferon-based antiviral?regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Leukemia. 2020 05; 34(5):1462-1466. PMID: 31836855.
      Citations: 8     Fields:    Translation:HumansCells
    27. Hwang JP, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK, Torres HA, Bailey HH. Oncologic Implications of Chronic Hepatitis C Virus Infection. J Oncol Pract. 2019 12; 15(12):629-637. PMID: 31825756.
      Citations: 4     Fields:    Translation:HumansCells
    28. Torres HA, Pundhir P, Mallet V. Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis. Gastroenterology. 2019 10; 157(4):909-916. PMID: 30797794.
      Citations: 7     Fields:    Translation:HumansCells
    29. Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2019 02; 114(2):250-257. PMID: 30410039.
      Citations: 5     Fields:    Translation:Humans
    30. Hwang JP, Torres HA. Hepatitis B virus and hepatitis C virus infection in immunocompromised patients. Curr Opin Infect Dis. 2018 12; 31(6):535-541. PMID: 30299355.
      Citations: 3     Fields:    Translation:Humans
    31. Hosry J, Angelidakis G, Kaseb A, Jiang Y, Torres HA. Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study. Clin Infect Dis. 2018 10 30; 67(10):1635-1636. PMID: 30124786; PMCID: PMC6206115.
      Citations:    Fields:    Translation:HumansCells
    32. Lu H, Lok AS, Warneke CL, Ahmed S, Torres HA, Martinez F, Suarez-Almazor ME, Foreman JT, Ferrajoli A, Hwang JP. Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. Lancet Haematol. 2018 Oct; 5(10):e474-e478. PMID: 30290904; PMCID: PMC6247917.
      Citations: 4     Fields:    Translation:Humans
    33. Raad II, Chaftari AM, Torres HA, Ayoub EM, Narouz LI, Bartek J, Hachem R. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World J Hepatol. 2018 Sep 27; 10(9):549-557. PMID: 30310533; PMCID: PMC6177572.
      Citations: 3     
    34. Angelidakis G, Sturgis EM, Economides MP, Jiang Y, Torres HA. Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers. Oral Oncol. 2018 10; 85:103-105. PMID: 30154040.
      Citations:    Fields:    Translation:HumansCells
    35. Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA. Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer. J Hepatocell Carcinoma. 2018; 5:81-86. PMID: 30123783; PMCID: PMC6080868.
      Citations: 3     
    36. Mak LY, Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK, Bailey HH, Yuen MF, Hwang JP, Cruz-Ram?n V, Chinchilla-L?pez P, M?ndez-S?nchez N. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:262-279. PMID: 30231359.
      Citations: 67     Fields:    Translation:HumansPHPublic Health
    37. Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol. 2018 Apr 01; 36(10):959-967. PMID: 29447061; PMCID: PMC7351320.
      Citations: 9     Fields:    
    38. Economides MP, Amit M, Mahale PS, Hosry JJ, Jiang Y, Bharadwaj U, Sturgis EM, Torres HA. Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer. 2018 03 01; 124(5):960-965. PMID: 29149493; PMCID: PMC5821521.
      Citations: 3     Fields:    Translation:HumansCells
    39. Torres HA, Hosry J, Mahale P, Economides MP, Jiang Y, Lok AS. Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. Hepatology. 2018 01; 67(1):36-47. PMID: 28653760; PMCID: PMC5739995.
      Citations: 21     Fields:    Translation:HumansCells
    40. Hosry J, Miranda RN, Samaniego F, Economides MP, Torres HA. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients. Int J Cancer. 2018 03 01; 142(5):940-948. PMID: 29047108; PMCID: PMC5760439.
      Citations: 3     Fields:    Translation:HumansCells
    41. Economides MP, Ballester LY, Kumar VA, Jiang Y, Tarrand J, Prieto V, Torres HA, Kontoyiannis DP. Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect. 2017 12; 75(6):572-580. PMID: 28919347.
      Citations: 6     Fields:    Translation:Humans
    42. Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A, Mallet V. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin. 2017 Sep; 67(5):411-431. PMID: 28683174; PMCID: PMC5591069.
      Citations: 24     Fields:    Translation:Humans
    43. Mahale P, Engels EA, Li R, Torres HA, Hwang LY, Brown EL, Kramer JR. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. Gut. 2018 03; 67(3):553-561. PMID: 28634198; PMCID: PMC6292199.
      Citations: 34     Fields:    Translation:Humans
    44. Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799. PMID: 28579181; PMCID: PMC5901750.
      Citations: 33     Fields:    Translation:Humans
    45. Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown EL, Engels EA. Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study. Cancer. 2017 04 01; 123(7):1202-1211. PMID: 28117886; PMCID: PMC6295146.
      Citations: 28     Fields:    Translation:HumansCells
    46. Arcaini L, Frigeni M, Goldaniga M, Casato M, Visentini M, Torres HA, Loustaud-Ratti V, Peveling-Oberhag J, Fabris P, Rossotti R, Zaja F, Rigacci L, Rattotti S, Bruno R, Merli M, Jaccard A, Ferretti VV, Visco C, Besson C, Fontaine H, Dorival C, Alric L, Pol S, Carrat F, Hermine O. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood. 2016 11 24; 128(21):2527-2532. PMID: 27605512.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    47. Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. J Natl Compr Canc Netw. 2016 09; 14(9):1185-8. PMID: 27587628.
      Citations: 1     Fields:    Translation:HumansCells
    48. Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer. 2016 12 01; 139(11):2519-28. PMID: 27501007; PMCID: PMC5028297.
      Citations: 13     Fields:    Translation:HumansCells
    49. Torres HA, McDonald GB. How I treat hepatitis C virus infection in patients with hematologic malignancies. Blood. 2016 09 15; 128(11):1449-57. PMID: 27443290; PMCID: PMC6033045.
      Citations: 9     Fields:    Translation:HumansCells
    50. Economides MP, Mahale P, Turturro F, Hosry J, Samaniego F, Granwehr BP, Torres HA. Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leuk Lymphoma. 2017 02; 58(2):485-488. PMID: 27348218.
      Citations: 5     Fields:    Translation:HumansCells
    51. Torres HA, Vauthey JN, Economides MP, Mahale P, Kaseb A. Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment. J Hepatol. 2016 10; 65(4):862-864. PMID: 27255582.
      Citations: 24     Fields:    Translation:Humans
    52. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association Between Hepatitis C Virus and Head and Neck Cancers. J Natl Cancer Inst. 2016 08; 108(8). PMID: 27075854; PMCID: PMC5017939.
      Citations: 22     Fields:    Translation:HumansCells
    53. Mahale P, Thomas SK, Kyvernitakis A, Torres HA. Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy. Open Forum Infect Dis. 2016 Jan; 3(1):ofv211. PMID: 26885541; PMCID: PMC4751339.
      Citations: 3     
    54. Jain P, Verstovsek S, Wang W, Loghavi S, Torres HA, Estrov Z, Patel KP, Pemmaraju N. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia. Leuk Lymphoma. 2016 08; 57(8):1969-73. PMID: 26700872; PMCID: PMC4919228.
      Citations: 2     Fields:    Translation:Humans
    55. Kyvernitakis A, Mahale P, Popat UR, Jiang Y, Hosry J, Champlin RE, Torres HA. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents. Biol Blood Marrow Transplant. 2016 Apr; 22(4):717-722. PMID: 26712592; PMCID: PMC4828726.
      Citations: 12     Fields:    Translation:HumansCells
    56. Mahale P, Turturro F, Romaguera JE, Fowler N, Torres HA. The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremia. Leuk Lymphoma. 2016; 57(6):1487-90. PMID: 26402559.
      Citations:    Fields:    Translation:HumansCells
    57. Iqbal T, Mahale P, Turturro F, Kyvernitakis A, Torres HA. Prevalence and association of hepatitis C virus infection with different types of lymphoma. Int J Cancer. 2016 Feb 15; 138(4):1035-7. PMID: 26356141.
      Citations: 11     Fields:    Translation:Humans
    58. Torres HA, Chong PP, De Lima M, Friedman MS, Giralt S, Hammond SP, Kiel PJ, Masur H, McDonald GB, Wingard JR, Gambarin-Gelwan M. Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations. Biol Blood Marrow Transplant. 2015 Nov; 21(11):1870-82. PMID: 26256943.
      Citations: 11     Fields:    Translation:HumansCells
    59. Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90. PMID: 26243649; PMCID: PMC4575402.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    60. Torres HA, Mahale P. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization. Liver Int. 2015 Jun; 35(6):1661-4. PMID: 25779000.
      Citations: 9     Fields:    Translation:HumansCells
    61. Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29. PMID: 25836985; PMCID: PMC4778392.
      Citations: 38     Fields:    Translation:Humans
    62. Kyvernitakis A, Taremi M, Blechacz B, Hwang J, Jiang Y, Mahale P, Torres HA. Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection. Hepatol Res. 2015 Nov; 45(11):1146-51. PMID: 25488194.
      Citations: 5     
    63. Torres HA, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DP. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50. PMID: 25583768.
      Citations: 11     Fields:    Translation:HumansCells
    64. Mahale P, Kaseb AO, Hassan MM, Torres HA. Hepatocellular carcinoma as a second primary cancer in patients with chronic hepatitis C virus infection. Dig Liver Dis. 2015 Apr; 47(4):348-9. PMID: 25563811.
      Citations: 3     Fields:    Translation:HumansCells
    65. Duvic M, Mahale P, Torres HA, Kyvernitakis A. Interferon-based treatment for patients with mycosis fungoides and hepatitis C virus infection: a case series. Am J Clin Dermatol. 2014 Oct; 15(5):451-6. PMID: 24934807.
      Citations: 1     Fields:    Translation:Humans
    66. Torres HA, Kaseb A, Mahale P, Miller E, Frenette C. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series. J Hepatocell Carcinoma. 2014; 1:109-14. PMID: 27508180; PMCID: PMC4918269.
      Citations: 2     
    67. Borchardt RA, Torres HA. Challenges in managing hepatitis C virus infection in cancer patients. World J Gastroenterol. 2014 Mar 21; 20(11):2771-6. PMID: 24659870; PMCID: PMC3961965.
      Citations: 9     Fields:    Translation:HumansCells
    68. Torres HA, Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy. Clin Infect Dis. 2014 Jul 01; 59(1):106-14. PMID: 24642555; PMCID: PMC4305124.
      Citations: 24     Fields:    Translation:Humans
    69. Hwang JP, Suarez-Almazor ME, Torres HA, Palla SL, Huang DS, Fisch MJ, Lok AS. Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract. 2014 May; 10(3):e167-74. PMID: 24594679; PMCID: PMC4018458.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    70. Kyvernitakis A, Jabbour E, Torres HA. Sustained virologic response after 6 weeks of therapy with a first-generation hepatitis C virus protease inhibitor. Clin Infect Dis. 2014 May; 58(9):1342-4. PMID: 24501385; PMCID: PMC4184347.
      Citations:    Fields:    Translation:HumansCells
    71. Mahale P, Okhuysen PC, Torres HA. Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals? Clin Gastroenterol Hepatol. 2014 Jun; 12(6):1051-4.e1. PMID: 24211293.
      Citations: 5     Fields:    Translation:HumansCells
    72. Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO. Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World J Hepatol. 2013 Jun 27; 5(6):332-5. PMID: 23805358; PMCID: PMC3692975.
      Citations: 2     
    73. Ellickalputhenpura BE, Torres HA. Histoplasmosis: an asymptomatic to life-threatening infection. JAAPA. 2012 Dec; 25(12):18, 25-6. PMID: 23599999.
      Citations:    Fields:    Translation:HumansAnimals
    74. Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis. 2012 Nov; 206(9):1367-71. PMID: 22927454; PMCID: PMC3466999.
      Citations: 16     Fields:    Translation:HumansCells
    75. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85. PMID: 22871500.
      Citations: 38     Fields:    Translation:HumansCells
    76. Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II. Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. J Clin Virol. 2012 Jul; 54(3):218-22. PMID: 22459004.
      Citations: 2     Fields:    Translation:HumansCells
    77. Torres HA, Adachi JA, Roach LR, Smith KM, Mahale PS, Davila M, Raad II. Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way. Clin Infect Dis. 2012 Mar 01; 54(5):740-2. PMID: 22322272; PMCID: PMC6276933.
      Citations: 4     Fields:    Translation:Humans
    78. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 2012 Jan 24; 9(3):156-66. PMID: 22271089.
      Citations: 51     Fields:    Translation:Humans
    79. Mahale P, Kaseb A, Davila M, Torres HA. The effect of transcatheter arterial chemoembolization on hepatitis C viremia. Oncologist. 2012; 17(9):e21-3. PMID: 23002170; PMCID: PMC3448418.
      Citations:    Fields:    Translation:Humans
    80. Aisenberg GM, Aisenberg G, Torres HA, Torres H, Tarrand J, Safdar A, Bodey G, Chemaly RF. Herpes simplex virus lower respiratory tract infection in patients with solid tumors. Cancer. 2009 Jan 01; 115(1):199-206. PMID: 19090003.
      Citations: 9     Fields:    Translation:HumansCells
    81. Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7. PMID: 18224662.
      Citations: 16     Fields:    Translation:Humans
    82. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8. PMID: 18166808.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    83. Torres HA, Chemaly RF. Viral infection or reactivation in patients during treatment with dasatinib: a call for screening? Leuk Lymphoma. 2007 Dec; 48(12):2308-9. PMID: 18067004.
      Citations: 3     Fields:    Translation:HumansCells
    84. Arias CA, Torres HA, Singh KV, Panesso D, Moore J, Wanger A, Murray BE. Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis. 2007 Nov 15; 45(10):1343-6. PMID: 17968832.
      Citations: 35     Fields:    Translation:HumansCells
    85. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007 Sep; 92(9):1216-23. PMID: 17666367.
      Citations: 20     Fields:    Translation:HumansCells
    86. Torres HA, Barnett BJ, Arduino RC. Alopecia associated with ritonavir-boosted atazanavir therapy. AIDS. 2007 Jun 19; 21(10):1391-2. PMID: 17545728.
      Citations:    Fields:    Translation:Humans
    87. Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol. 2007 Jun; 102(6):1334-5. PMID: 17531028.
      Citations: 2     Fields:    Translation:Humans
    88. Torres HA, Arduino RC. Fosamprenavir calcium plus ritonavir for HIV infection. Expert Rev Anti Infect Ther. 2007 Jun; 5(3):349-63. PMID: 17547501.
      Citations: 4     Fields:    Translation:HumansCells
    89. Torres HA, Barnett BJ, Arduino RC. Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis. 2007 Mar 15; 44(6):887-8. PMID: 17304468.
      Citations: 1     Fields:    Translation:Humans
    90. Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007 Apr 01; 44(7):964-7. PMID: 17342649.
      Citations: 19     Fields:    Translation:Humans
    91. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8. PMID: 16640816.
      Citations: 11     Fields:    Translation:Humans
    92. Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb; 27(2):195-7. PMID: 16465639.
      Citations:    Fields:    Translation:HumansCells
    93. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85. PMID: 16310149.
      Citations: 69     Fields:    Translation:HumansAnimals
    94. Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus pneumonia in patients with lymphoma. Cancer. 2005 Sep 15; 104(6):1213-20. PMID: 16078263.
      Citations: 9     Fields:    Translation:Humans
    95. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79. PMID: 16143517.
      Citations: 8     Fields:    Translation:Humans
    96. Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7. PMID: 15844093.
      Citations: 10     Fields:    Translation:Humans
    97. Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis. 2005 May; 52(1):15-20. PMID: 15878437.
      Citations: 11     Fields:    Translation:HumansAnimals
    98. Steinbach WJ, Benjamin DK, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis. 2004 Jul 15; 39(2):192-8. PMID: 15307028.
      Citations: 82     Fields:    Translation:Humans
    99. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9. PMID: 15370667.
      Citations: 32     Fields:    Translation:HumansAnimals
    100. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21. PMID: 14530780.
      Citations: 30     Fields:    Translation:HumansAnimals
    101. Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9. PMID: 12872348.
      Citations: 50     Fields:    Translation:Humans
    102. Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003 Jul 01; 98(1):86-93. PMID: 12833460.
      Citations: 23     Fields:    Translation:Humans
    103. Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8. PMID: 12742315.
      Citations: 16     Fields:    Translation:HumansAnimals
    104. Torres HA, Rivero GA, Kontoyiannis DP. Endemic mycoses in a cancer hospital. Medicine (Baltimore). 2002 May; 81(3):201-12. PMID: 11997717.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    105. Reddy BT, Torres HA, Kontoyiannis DP. Breast implant infection caused by Trichosporon beigelii. Scand J Infect Dis. 2002; 34(2):143-4. PMID: 11928852.
      Citations: 11     Fields:    Translation:HumansAnimals
    106. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia. Leukemia and Lymphoma. 1-5.
    107. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents. Biology of Blood and Marrow Transplantation. 22:717-722.
    108. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer. Alimentary Pharmacology and Therapeutics. 44:1235-1241.
    109. Hyalohyphomycoses (hyaline moulds). 281-304.
    110. Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals. Journal of Hepatology. 65:862-864.
    111. How I treat hepatitis C virus infection in patients with hematologic malignancies. Blood. 128:1449-1457.
    112. Association between hepatitis C virus and head and neck cancers. Journal of the National Cancer Institute. 108.
    113. Authors' reply. Nature Reviews Clinical Oncology. 9:350.
    114. Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. Bone Marrow Transplantation.
    115. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis. Clinical Microbiology and Infection.
    116. Management of multiple myeloma complicated by hepatitis C virus reactivation. Open Forum Infectious Diseases. 3.
    117. Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leukemia and Lymphoma. 1-4.
    118. Erratum. Cancer. 115:1586.
    119. Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation. Bone Marrow Transplantation.
    120. HIV testing in patients with cancer at the initiation of therapy at a large US Comprehensive Cancer Center. Journal of Oncology Practice. 11:384-390.
    121. The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremia. Leukemia and Lymphoma.
    122. Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection. Hepatology Research. 45:1146-1151.
    123. Transdisciplinary approach to managing hepatitis c virus infection in patients at a tertiary care cancer center. JNCCN Journal of the National Comprehensive Cancer Network. 14:1185-1188.
    TORRES's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (340)
    Explore
    _
    Co-Authors (90)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _